评估质母细胞瘤的短期幸存者:基于SEER注册数据的提案
Yusuke Tomita1,2, Yoshihiro Otani3, Ryo Omae3
1Department of Neurological Surgery, Okayama University Medical School, Okayama, Japan.
Neuro-oncology advances
|May 16, 2025
概括
这项研究分析了质母细胞瘤 (GBM) 存活率数据,发现年龄和性别影响长期存活率. 短期幸存者通常死于其他原因,突出 GBM 研究中需要精确的死亡原因数据.
科学领域:
- 神经瘤学神经瘤学
- 流行病学 流行病学
- 癌症研究 癌症研究
背景情况:
- 质母细胞瘤 (GBM) 是具有不良预后的侵袭性脑瘤.
- 对于GBM生存的预后因素的了解有限.
- 描述GBM趋势和生存率对于改善患者的治疗结果至关重要.
研究的目的:
- 为了彻底描述美国的质母细胞瘤 (GBM).
- 分析不同年龄组的发病率,死亡率和生存趋势.
- 为了确定短期和长期GBM幸存者的预后因素.
主要方法:
- 使用了监测,流行病学和最终结果 (SEER) 数据库 (2000-2021).
- 提取年龄调整的发病率和死亡率 (AAIR,AAMR).
- 应用了Fine-Gray竞争风险模型来分析短期幸存者 (STS) 和长期幸存者 (LTS) 的生存数据.
主要成果:
- 包括超过6万个GBM病例,超过47,000个有生存数据.
- 在STS中,死亡率与发病率保持不变,但在LTS中,随着年龄的增长而增加.
- 年龄较大和男性性别预测LTS的GBM特异性死亡;非西班牙裔白人种族和不那么密集的治疗预测STS的GBM特异性死亡.
结论:
- 短期幸存者 (STSs) 可能包括因非GBM原因死亡的个人.
- 准确的GBM特定死亡的分类对于STS的可重复性研究至关重要.
- 未来的研究应该在STS中区分死亡原因,以便更清晰的预后因素分析.
相关概念视频
01:21Cancer Survival Analysis
311
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311
01:24Kaplan-Meier Approach
62
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
62
01:20Actuarial Approach
49
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
49
01:20Comparing the Survival Analysis of Two or More Groups
96
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
96